Nephrosis: Clinical Trials

23 trials for Nephrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed. 23 Phase 2, 5 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 223Completed 23
Phase 35Completed 5
Phase 12Completed 2

Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome
Rituximab - Steroid-Sensitive Nephrotic Syndrome
Phase 2CompletedChildren's Hospital of Fudan University442021-04-132023-07-11
Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
Dalteparin, Apixaban - Nephrotic Syndrome, Thromboembolic Disease
Phase 1 / Phase 2CompletedUniversity of Aarhus572021-03-252025-04-11
Personalized Medicine for Membranous Nephropathy
Rituximab - Idiopathic Membranous Nephropathy
Phase 2CompletedCentre Hospitalier Universitaire de Nice682020-01-142025-07-25
Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
adalimumab - FSGS, MCD
Phase 2CompletedUniversity of Michigan72019-10-022024-10-30
Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome
immunoglobulin IV - Steroid-Dependent Nephrotic Syndrome
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris732019-04-032026-10-29
Reduce Immunosuppression With Atmp in NS ChildrEn
Cord-blood mesenchymal stromal cells - Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome
Phase 2CompletedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico202018-11-022023-09-28
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
CXA-10 - Primary Focal Segmental Glomerulosclerosis
Phase 2CompletedComplexa, Inc.332018-04-152020-08-03
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
Abatacept, Normal Saline, D5W - Nephrotic Syndrome, Focal Segmental Glomerulosclerosis
Phase 2CompletedBristol-Myers Squibb362016-03-092021-03-05
Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome
Ofatumumab, Rituximab - Nephrotic Syndrome
Phase 2CompletedIstituto Giannina Gaslini1402015-06-012020-07-30
A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
Losmapimod - Glomerulosclerosis, Focal Segmental
Phase 2CompletedGlaxoSmithKline172014-07-012017-06-12
Eculizumab in Primary MPGN
Eculizumab - Membranoproliferative Glomerulonephritis
Phase 2CompletedMario Negri Institute for Pharmacological Research102014-03-012018-01-17
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
RE-021 (Sparsentan), Irbesartan - Focal Segmental Glomerulosclerosis
Phase 2CompletedTravere Therapeutics, Inc.1092014-03-012025-05-15
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Repository Corticotropin Injection, Placebo - Diabetic Nephropathy
Phase 2CompletedMallinckrodt342012-05-012019-11-18
IL-2 for Multi Drug Resistant Nephrotic Syndrome
Proleukin® - Nephrotic Syndrome
Phase 1 / Phase 2CompletedIstituto Giannina Gaslini52012-02-012015-05-28
Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood
Rituximab, Placebo - Childhood Idiopathic Nephrotic Syndrome
Phase 2 / Phase 3CompletedUniversity Hospital, Limoges262010-12-012015-03-23
Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome
Tacrolimus - Minimal Change Disease
Phase 2 / Phase 3CompletedSeoul National University Hospital202010-06-012011-08-16
Podocyte Retinoids
Isotretinoin - Collapsing Glomerulopathy, Glomerulosclerosis, Focal Segmental
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)122004-11-262017-12-13
Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
tacrolimus combined with prednisone - Idiopathic Membranous Nephropathy, Nephrotic Syndrome
Phase 2 / Phase 3CompletedPeking University2004-11-012006-08-10
Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
Sirolimus - Membranous Glomerulonephritis, Lupus Membranous Nepropathy
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)122002-12-172017-10-06
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
NC-503 (Anti-amyloidotic (AA) Agent) - Secondary (AA) Amyloidosis, Rheumatoid Arthritis
Phase 2 / Phase 3CompletedBellus Health Inc. - a GSK company1502001-10-012006-02-14

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Nephrotic Syndrome (22)  ·  Glomerulosclerosis, Focal Segmental (8)  ·  Proteinuria (8)  ·  Nephrosis, Lipoid (5)  ·  Glomerulonephritis, Membranous (4)  ·  Kidney Diseases (4)  ·  Glomerulonephritis (3)  ·  Fibrosis (2)  ·  Amyloidosis (1)  ·  Arthritis, Rheumatoid (1)  ·  Camurati-Engelmann Syndrome (1)  ·  Diabetic Nephropathies (1)  ·  Familial Mediterranean Fever (1)  ·  Gastrointestinal Diseases (1)  ·  Glomerulonephritis, Membranoproliferative (1)

Broader conditions

Female Urogenital Diseases (23)  ·  Female Urogenital Diseases and Pregnancy Complications (23)  ·  Male Urogenital Diseases (23)  ·  Urogenital Diseases (23)  ·  Urologic Diseases (23)  ·  Kidney Diseases (19)  ·  Nephritis (13)  ·  Glomerulonephritis (10)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (8)  ·  Urination Disorders (8)  ·  Urological Manifestations (8)  ·  Immune System Diseases (7)  ·  Autoimmune Diseases (6)

Interventions

Rituximab (4)  ·  Prednisone (2)  ·  6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide (1)  ·  Abatacept (1)  ·  Adalimumab (1)  ·  Adrenocorticotropic Hormone (1)  ·  CXA-10 (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Dalteparin (1)  ·  Dexamethasone (1)  ·  Glucose (1)  ·  Interleukin-2 (1)  ·  Irbesartan (1)  ·  Isotretinoin (1)

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5)  ·  Istituto Giannina Gaslini (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bellus Health Inc. - a GSK company (1)  ·  Bristol-Myers Squibb (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Children's Hospital of Fudan University (1)  ·  Complexa, Inc. (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  GlaxoSmithKline (1)  ·  Mallinckrodt (1)  ·  Mario Negri Institute for Pharmacological Research (1)  ·  Peking University (1)  ·  Seoul National University Hospital (1)  ·  Travere Therapeutics, Inc. (1)

Countries

United States (12)  ·  Italy (6)  ·  France (4)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Israel (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  South Korea (1)

Top investigators

Fanfan Hou, MD (1)  ·  Feifei Xu, MD (1)  ·  Fuming Lu, MD (1)  ·  Gian Marco Ghiggeri, MD (1)  ·  Gianmarco Ghiggeri, MD (1)  ·  Howard A Austin, M.D. (1)  ·  Howard Trachtman, M.D. (1)  ·  Jeffrey B Kopp, M.D. (1)  ·  Jianghua Chen, MD (1)  ·  Jiaqi Qian, MD (1)

Results publications

PMID 39513526, PMID 35224732, PMID 40337980, PMID 17554116, PMID 25457107, PMID 26413873, PMID 28314744, PMID 30361325, PMID 32903623, PMID 32967877, PMID 34544820, PMID 34778952, PMID 35230699, PMID 36223961, PMID 36456193, PMID 36657027, PMID 38724717, PMID 38831932, PMID 39808779, PMID 40478760, PMID 41333097

NIH funding

2015 (1), 2017 (1), 2018 (1)